《大行報告》野村微降國壽(02628.HK)目標價至16.41元 評級「買入」
野村發表研究報告,預期國壽(02628.HK)首九個月的純利按年跌32%至329億元人民幣,意味著第三季純利按年跌1%至75億元人民幣,主要受投資疲弱拖累。料其首九個月的新業務價值按年跌13%至331億元人民幣,意味著第三季跌10%,主因疫情「封城」影響。
該行對國壽的2022及2023財年純利預測分別下調14%及9.5%,至按年跌27%及增長29%。同時下調其2022財年新業務價值1%,至按年跌12%。維持對其「買入」評級,目標價由16.65元微降至16.41元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.